Introduction {#S1}
============

Sponges are among the most primitive multicellular invertebrates and harbor vast microbial populations, owing largely to the unique filter-feeding physiology that is full of pores and channels ([@B13]; [@B38]). As a result of the long-standing interaction and coevolution with sponges, marine symbiotic microorganisms have differentiated from those of terrestrial origins in terms of their biosynthetic pathways that lead to the production of structurally interesting and biologically active compounds ([@B34]; [@B11]). Therefore, sponge-associated microbes have become an exciting area of drug discovery research ([@B34]; [@B28]). Endophytic fungi that are associated with sponges, especially members of the genus *Aspergillus*, have been recognized as a source of structurally diverse natural products with biological activities that provide value for drug discovery ([@B2]; [@B41]). In the past decade, the secondary metabolites from sponge-derived *Aspergillus* fungi have been reported from many classes, including polyketides ([@B37]; [@B17]), terpenoids ([@B25]; [@B21]), alkaloids ([@B42], [@B43]), diketopiperazines ([@B1]), and peptides ([@B19]). Many of these metabolites have been shown to exhibit strong antitumor, antibacterial, antiviral, and other bioactivities.

Isocoumarins and 3,4-dihydroisocoumarins, subclasses of polyketide compounds, are also lactone-containing natural products that are abundantly produced among fungi, bacteria, liverworts, lichens, as well as some higher plants ([@B10]; [@B31]; [@B15]; [@B6]). Moreover, these compounds have been isolated from marine sponges, insect pheromones, and venoms ([@B31]). Almost 400 isocoumarins and dihydroisocoumarins have been reported to date, and these compounds have been found to be of broad interest across many pharmacological applications ([@B31]; [@B6]). For example, isocoumarin derivatives from some marine-derived fungi are found to possess a wide range of biological properties including enzyme inhibitory ([@B16]; [@B7]; [@B39]; [@B3]), cytotoxic ([@B36]; [@B40]), antibacterial ([@B22]; [@B20]; [@B5]; [@B36]), antiproliferative ([@B35]), anti-food allergic ([@B27]), as well as anti-inflammatory ([@B16]; [@B5]; [@B26]) activities.

As part of a continuing research program investigating the biologically active secondary metabolites from sponge-derived fungi ([@B9]; [@B14]; [@B23]), a detailed chemical investigation was initiated on the culture of fungus *Aspergillus* sp. NBUF87. The fungus was isolated from a South China Sea marine sponge of the genus *Hymeniacidon*. The EtOAc extract of the culture of fungus *Aspergillus* sp. NBUF87 exhibited inhibitory effects on the root growth of *Arabidopsis thaliana* Columbia-0 (Col-0), a typical model organism for studying plant growth and development. The separation and purification of the bioactive extract led to the discovery of six new dihydroisocoumarin compounds (**1**−**6**) and five known analogs (**7**−**11**) ([Figure 1](#F1){ref-type="fig"}). Herein, the detailed isolation and structure elucidation of these dihydroisocoumarin derivatives, together with the evaluation of their inhibitory effects against the root growth of Col-0 and a preliminary broader biological activity screening are described.

![Structures of isolated dihydroisocoumarin derivatives (**1**--**11**).](fmicb-10-02846-g001){#F1}

Materials and Methods {#S2}
=====================

General Experimental Procedures {#S2.SS1}
-------------------------------

Optical rotation measurements were conducted with a JASCO P-2000 digital polarimeter. IR and UV spectra were obtained with a Thermo Scientific Nicolet iS5 FT-IR spectrometer and a Thermo Scientific Evolution 201 spectrophotometer, respectively. Electronic circular dichroism (ECD) spectra were collected on a JASCO J-1500 spectrophotometer. 1D and 2D NMR spectra were recorded in DMSO-*d*~6~ (or CDCl~3~) with a Palo Alto Varian 600 MHz spectrometer, using standard pulse sequences. HRESIMS data were collected on an Agilent Technologies 6224 TOF MS. X-ray single-crystal diffraction data were acquired using an Agilent Gemini Ultra diffractometer with Cu Kα radiation (λ = 1.54178 Å). Medium-pressure liquid chromatography (MPLC) was performed using a Bonna-Agela FLEXA purification instrument. Column chromatography (CC) was carried out with silica gel (200−300 mesh, Qingdao) and Amersham Biosciences Sephadex LH-20. Reversed-phase HPLC (RP-HPLC) was conducted using a Waters 1525 binary HPLC pump equipped with a Waters 2996 photodiode array detector and a YMC-Pack C18 column (YMC, 20 × 250 mm, 5 μm).

Fungal Material {#S2.SS2}
---------------

The fungus *Aspergillus* sp. NBUF87 was isolated from the sponge *Hymeniacidon* sp. obtained from the Paracel Islands in the South China Sea, and was determined as being *Aspergillus* sp. by its morphology and gene sequence (ITS rDNA region) analyses (GenBank accession no. [MH595747.1](MH595747.1)). The strain specimen was deposited in PDB medium to the repository conserved at the College of Food and Pharmaceutical Sciences, Ningbo University, China.

Fermentation, Extraction, and Isolation {#S2.SS3}
---------------------------------------

Spores of *Aspergillus* sp. NBUF87 were initially inoculated into Erlenmeyer flasks (1 L) containing 400 mL of the seed medium (potato dextrose broth powder 26 g/L and sea salt 35 g/L dissolved in distilled water) and were grown on a shaker (150 r/min) for 100 h at 28°C. The subsequent amplified fermentation was conducted in 105 × 1 L Erlenmeyer flasks, each containing solid rice medium (rice 120 g, sea salt 6.3 g, purified H~2~O 180 mL), followed by inoculation with 30 mL of the seed culture. After fermentation at room temperature under static conditions for 6 weeks, the fermented substrate was repeatedly extracted with EtOAc. Removal of EtOAc under reduced pressure yielded 54 g of crude extract, which was subjected to vacuum liquid chromatography (VLC) on silica gel column eluting with a petroleum ether/EtOAc stepwise gradient system (from 1:0 to 0:1) to generate seven fractions (Fr. 1−7).

Fraction 4 (3.9 g) was subjected to Sephadex LH-20 gel filtration chromatography, eluted with isocratic CH~2~Cl~2~-CH~3~OH (1:1, v/v) to furnish five sub-fractions (Fr. 4A−4F). The further separation of Fr. 4E (1.8 g) was conducted by reversed-phase ODS MPLC with a gradient elution of CH~3~OH/H~2~O (from 25 to 100% CH~3~OH, flow rate 20 mL/min, 180 min, UV detection at 210 nm) to afford 60 test tube sub-fractions. Subsequently, aspergimarin A (**1**, 15.3 mg, *t*~R~ 33.4 min) was purified from Fr. 4E-20 by semi-preparative RP-HPLC \[YMC-Pack C18 column (YMC, 20 × 250 mm, 5 μm), UV detection at 210 and 246 nm\] with 28% CH~3~CN/H~2~O at 2 mL/min. Aspergimarin E (**5**, 3.6 mg, *t*~R~ 40.2 min), compounds **10** (4.3 mg, *t*~R~ 72.3 min) and **11** (4.7 mg, *t*~R~ 58.2 min) were purified from Fr. 4E-19 by semi-preparative RP-HPLC with 24% CH~3~CN/H~2~O at 2 mL/min. Aspergimarin F (**6**, 3.4 mg, *t*~R~ 57.3 min) was purified from Fr. 4E-18 by semi-preparative RP-HPLC with 24% CH~3~CN/H~2~O at 2 mL/min. Fr. 4B (1.0 g) was conducted by MPLC (30−90% CH~3~OH/H~2~O, flow rate 20 mL/min, 120 min, UV detection at 210 nm) to produce 10 sub-fractions (Fr. 4B-1−4B-10). Fr. 4B-4 was further purified by semi-preparative RP-HPLC with 42% CH~3~OH/H~2~O at 2 mL/min to yield compound **9** (43.1 mg, *t*~R~ 45.0 min). Fr. 4B-8 was further purified by semi-preparative RP-HPLC with 60% CH~3~OH/H~2~O at 2 mL/min to afford compound **7** (56.0 mg, *t*~R~ 26.7 min) ([Supplementary Figures S1](#SM1){ref-type="supplementary-material"}--[S10](#SM1){ref-type="supplementary-material"}, [S41](#SM1){ref-type="supplementary-material"}--[S60](#SM1){ref-type="supplementary-material"}).

Fraction 5 (4.8 g) was separated by Sephadex LH-20 gel filtration chromatography utilizing an isocratic elution gradient of CH~2~Cl~2~−CH~3~OH (1:1, v/v) to afford three sub-fractions (Fr. 5A−5C). The further separation of Fr. 5B (2.5 g) was conducted by RP-MPLC (ODS, 15−100% CH~3~OH/H~2~O, flow rate 20 mL/min, 140 min, UV detection at 210 nm) to give 35 tubes. Aspergimarin B (**2**, 2.5 mg, *t*~R~ 31.4 min) and aspergimarin C (**3**, 3.8 mg, *t*~R~ 22.9 min) were further purified from Fr.5B-23 by semi-preparative RP-HPLC with 30% CH~3~CN/H~2~O at 4 mL/min. Fr. 5A (0.9 g) was separated by MPLC (ODS, 25−100% CH~3~OH/H~2~O, flow rate 20 mL/min, 150 min, UV detection at 210 nm) to obtain 38 tubes. Fr.5A-15 was further purified by semi-preparative RP-HPLC with 25% CH~3~CN/H~2~O at 4 mL/min to afford aspergimarin D (**4**, 6.3 mg, *t*~R~ 31.0 min). Fr. 5A-14 was purified by semi-preparative RP-HPLC with 22% CH~3~CN/H~2~O at 4 mL/min to afford compound **8** (26.1 mg, *t*~R~ 31.6 min) ([Supplementary Figures S11--S40](#SM1){ref-type="supplementary-material"}).

*Aspergimarin A* (***1***): white, crystals; mp 177.9−178.8 °C; \[α\]20 D −34.0 (*c* 0.2, CHCl~3~); UV (MeOH) λ~max~ (log ε): 219 (4.14), 248 (3.77), 346 (3.58) nm; CD (*c* = 0.68 mM, MeOH) λ~max~ (Δε): 223 (+ 2.15), 237 (−1.93), 245 (−1.10), 259 (−6.32) nm; IR (KBr) ν~max~: 3205, 1647, 1588, 1483, 1354, 1281, 820, 795, 700 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#T1){ref-type="table"}; HRESIMS *m/z* 265.1082 \[M − H\] ^--^ (calcd for C~14~H~17~O~5~, 265.1081).

###### 

^1^H (600 MHz) and ^13^C (150 MHz) NMR data of **1**−**3** collected in DMSO-*d*~6~.

  **Position**   **1**                                        **2**         **3**                                                                                                   
  -------------- -------------------------------------------- ------------- -------------------------------------------- ------------- -------------------------------------------- -------------
  1                                                           169.5, C                                                   169.5, C                                                   169.5, C
  3              4.59, m                                      79.4, CH      4.59, m                                      79.2, CH      4.59, m                                      79.2, CH
  4              3.06, dd (16.9, 3.4) 2.60, dd (16.9, 11.6)   26.3, CH~2~   3.05, dd (16.9, 3.3) 2.60, dd (16.9, 11.5)   26.4, CH~2~   3.05, dd (16.9, 3.4) 2.60, dd (16.9, 11.5)   26.3, CH~2~
  4a                                                          124.5, C                                                   124.0, C                                                   124.5, C
  5                                                           146.6, C                                                   145.7, C                                                   145.6, C
  6              7.07, d (8.9)                                123.9, CH     7.06, d (8.9)                                124.0, CH     7.06, d (8.9)                                123.9, CH
  7              6.72, d (8.9)                                115.1, CH     6.72, d (8.9)                                115.2, CH     6.72, d (8.9)                                115.2, CH
  8                                                           153.9, C                                                   153.9, C                                                   153.9, C
  8a                                                          108.2, C                                                   108.3, C                                                   108.2, C
  1′             1.78, m 1.68, m                              34.3, CH~2~   1.76, m 1.70, m                              33.9, CH~2~   1.74, m                                      33.9, CH~2~
  2′             1.46, m                                      20.8, CH~2~   1.44, m                                      20.3, CH~2~   1.46, m                                      20.3, CH~2~
  3′             1.36, m                                      38.6, CH~2~   1.55, m                                      34.9, CH~2~   1.55, m                                      34.9, CH~2~
  4′             3.60, m                                      65.6, CH      4.83, m                                      70.2, CH      4.83, m                                      69.8, CH
  5′             1.05, d (6.2)                                23.7, CH~3~   1.16, d (6.3)                                19.8, CH~3~   1.17, d (6.2)                                19.8, CH~3~
  1′′                                                                                                                    171.8, C                                                   170.4, C
  2′′                                                                       2.45, m 1.24, m                              28.9, CH~2~   2.38, m                                      46.9, CH~2~
  3′′                                                                       2.46, m                                      29.1, CH~2~                                                69.8, C
  4′′                                                                                                                    173.5, C      1.67, m                                      43.7, CH~2~
  5′′                                                                                                                                  3.54, m                                      57.2, CH~2~
  6′′                                                                                                                                  1.18, s                                      27.4, CH~3~
  8-OH           10.38, s                                                   10.37, s                                                   10.37, s                                     
  3′′-OH                                                                                                                               4.53, s                                      
  5′′-OH                                                                                                                               4.36, s                                      

s, singlet; d, doublet; dd, doublet of doublets; m, multiplet.

*Aspergimarin B* (***2***): brown, oil; \[α\]24 D −10.6 (*c* 0.2, MeOH); UV (MeOH) λ~max~ (log ε): 211 (4.24), 345 (3.66) nm; CD (*c* = 0.33 mM, MeOH) λ~max~ (Δε): 225 (+ 0.88), 235 (−1.54), 243 (−0.81), 257 (−5.77) nm; IR (KBr) ν~max~: 3226, 2929, 1723, 1675, 1469, 1379, 1207, 829 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#T1){ref-type="table"}; HRESIMS *m/z* 365.1232 \[M − H\] ^--^ (calcd for C~18~H~21~O~8~, 365.1242).

*Aspergimarin C* (***3***): brown, oil; \[α\]24 D −10.8 (*c* 0.3, MeOH); UV (MeOH) λ~max~ (log ε): 219 (4.27), 344 (3.63) nm; CD (*c* = 0.45 mM, MeOH) λ~max~ (Δε): 229 (+ 0.86), 238 (−1.44), 243 (−0.32), 257 (−5.37) nm; IR (KBr) ν~max~: 3368, 2921, 1671, 1469, 1378, 1287, 1206, 1123 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#T1){ref-type="table"}; HRESIMS *m/z* 435.1416 \[M + K\]^+^ (calcd for C~20~H~28~KO~8~, 435.1415).

*Aspergimarin D* (***4***): yellow, oil; \[α\]24 D −82.2 (*c* 0.5, MeOH); UV (MeOH) λ~max~ (log ε): 214 (4.16), 312 (3.24) nm; CD (*c* = 0.68 mM, MeOH) λ~max~ (Δε): 221 (−6.98), 241 (−0.28), 256 (−2.47), 284 (−0.48), 311 (−1.61) nm; IR (KBr) ν~max~: 3402, 2935, 1717, 1489, 1455, 1418, 1259, 1131, 1052, 963 cm^--1^; ^1^H and ^13^C NMR data, see [Table 2](#T2){ref-type="table"}; HRESIMS *m/z* 295.1537 \[M + H\]^+^ (calcd for C~16~H~23~O~5~, 295.1540).

###### 

^1^H (600 MHz) and ^13^C (150 MHz) NMR data of **4**--**6**.

  **Position**   **4 (DMSO-*d*~6~)**                          **5 (CDCl~3~)**   **6 (DMSO-*d*~6~)**                                                              
  -------------- -------------------------------------------- ----------------- --------------------- ------------- -------------------------------------------- -------------
  1                                                           161.5, C                                168.7, C                                                   169.8, C
  3              4.37, m                                      78.1, CH          4.47, m               83.6, CH      4.61, m                                      79.9, CH
  4              2.91, dd (16.1, 3.1) 2.76, dd (16.1, 11.2)   32.7, CH~2~       4.71, d (7.5)         67.5, CH      2.91, dd (16.2, 3.3) 2.80, dd (16.2, 11.4)   31.4, CH~2~
  4a                                                          132.3, C                                141.7, C                                                   129.3, C
  5              7.06, d (8.3)                                122.7, CH         7.03, d (7.4)         116.3, CH     6.63, d (8.0)                                117.5, CH
  6              7.28, d (8.3)                                117.7, CH         7.54, t (8.4, 7.4)    137.0, CH     7.00, d (8.0)                                121.6, CH
  7                                                           152.2, C          6.69, d (8.4)         117.9, CH                                                  144.4, C
  8                                                           150.1, C                                162.1, C                                                   150.0, C
  8a                                                          119.0, C                                106.8, C                                                   108.4, C
  1′             1.70, m 1.60, m                              34.1, CH~2~       1.87, m 1.82, m       31.5, CH~2~   1.71, m 1.63, m                              33.3, CH~2~
  2′             1.44, m                                      20.9, CH~2~       1.71, m 1.63, m       21.0, CH~2~   1.65, m 1.57, m                              18.7, CH~2~
  3′             1.34, m                                      38.7, CH~2~       1.51, m               38.7, CH~2~   2.51, t (6.2)                                42.1, CH~2~
  4′             3.59, m                                      65.7, CH          3.85, m               67.9, CH                                                   208.2, C
  5′             1.04, d (6.1)                                23.7, CH~3~       1.21, d (6.2)         23.9, CH~3~   2.08, s                                      29.8, CH~3~
  7-OCH~3~       3.81, s                                      56.1, CH~3~                                                                                        
  8-OCH~3~       3.75, s                                      60.7, CH~3~                                                                                        
  8-OH                                                                          10.97, s                                                                         

s, singlet; d, doublet; dd, doublet of doublets; t, triplet; m, multiplet.

*Aspergimarin E* (***5***): colorless, oil; \[α\]24 D + 17.7 (*c* 0.3, MeOH); UV (MeOH) λ~max~ (log ε): 209 (4.17), 246 (3.52), 312 (3.42) nm; CD (*c* = 0.56 mM, MeOH) λ~max~ (Δε): 206 (−8.37), 218 (−0.47), 224 (−1.04), 243 (+ 3.53), 264 (−0.71), 280 (−0.01), 311 (−0.53) nm; IR (KBr) ν~max~: 3367, 2920, 1672, 1461, 1230, 1117, 823 cm^--1^; ^1^H and ^13^C NMR data, see [Table 2](#T2){ref-type="table"}; HRESIMS *m/z* 289.1034 \[M + Na\]^+^ (calcd for C~14~H~18~NaO~5~, 289.1046).

*Aspergimarin F* (***6***): yellow, amorphous powder; \[α\]24 D −7.5 (*c* 0.2, MeOH); UV (MeOH) λ~max~ (log ε): 221 (4.14), 256 (3.71), 332 (3.44) nm; CD (*c* = 0.57 mM, MeOH) λ~max~ (Δε): 208 (−8.75), 240 (+ 2.67), 266 (−1.47) nm; IR (KBr) ν~max~: 3360, 2920, 2849, 2361, 1707, 1664, 1452, 1272, 1135, 668 cm^--1^; ^1^H and ^13^C NMR data, see [Table 2](#T2){ref-type="table"}; HRESIMS *m/z* 287.0879 \[M + Na\]^+^ (calcd for C~14~H~16~NaO~5~, 287.0890).

X-Ray Crystal Structure Analysis of **1** {#S2.SS4}
-----------------------------------------

A single crystal of **1** was obtained from 90% CH~3~OH/H~2~O. Crystal X-ray diffraction data was collected on an Agilent Gemini Ultra diffractometer with Cu Kα radiation (λ = 1.54178 Å). The structure was solved by direct methods (SHELXS−97) and refined with full-matrix least-squares difference Fourier techniques. All non-hydrogen atoms were refined anisotropically, and hydrogen atoms were placed in the idealized geometrical positions and refined isotropically with a riding model. Crystallographic data for **1** have been deposited in the Cambridge Crystallographic Data Center as supplementary publication no. CCDC 1919904. Copies of the data can be obtained, free of charge, on application to the Director, CCDC, 12 Union Road, Cambridge CB21EZ, United Kingdom (fax: + 44-(0)1223-336033, or e-mail: <deposit@ccdc.cam.ac.uk>).

*Crystal data of aspergimarin A* (***1***): C~14~H~18~O~5~, *M*~R~ = 266.28, monoclinic, *a* = 4.9195(3) Å, *b* = 24.7434(17) Å, *c* = 5.6478(4) Å, α = γ = 90°, β = 101.812(2)°, *V* = 672.92(8) Å^3^, space group *P*2~1~, *Z* = 2, *D*~c~ = 1.314 mg/m^3^, μ = 0.829 mm^--1^, and *F*(000) = 284. Crystal size: 0.200 × 0.170 × 0.130 mm^3^. Independent reflections: 2294 (*R*~int~ = 0.0377). Final *R* indices \[*I* \> 2 sigma (*I*)\], *R*~1~ = 0.0717, *wR*~2~ = 0.2076. Goodness of fit on *F*^2^ was 1.109.

Preparation of MTPA Esters of **3**−**5** for Modified Mosher's Analysis {#S2.SS5}
------------------------------------------------------------------------

Under an atmosphere of nitrogen, pyridine-*d*~5~ (500 μL) and (*R*)-MTPA-Cl (8 μL) was sequentially added to an EP tube containing compounds **3**, **4**, or **5** (1.0 mg), separately. The mixture was shaken at 28 °C for 12 h and then purified by RP-HPLC to obtain the (*S*)-MTPA esters **3a**, **4a**, and **5a**. By the same procedure, the (*R*)-MTPA esters **3b**, **4b**, and **5b** were obtained using (*S*)-MTPA-Cl as a reagent. Key ^1^H NMR signals used for configurational assignments were determined by respective ^1^H−^1^H COSY correlations and the already completed full assignments of ^1^H NMR data for **3**, **4**, and **5** (see [Supplementary Figures S61--S72](#SM1){ref-type="supplementary-material"}).

The C-3′′ absolute configuration of **3** were established as *R* on the basis of the Δδ values (Δδ~H--2\^″~: −0.01; Δδ~H--4\^″~: + 0.03; Δδ~H--5\^″~: + 0.01) of the (*S*)- and (*R*)-MTPA esters (**3a** and **3b**). **3a**: H-2′′ (δ~H~ 2.37), H-4′′ (δ~H~ 1.89), H-5′′ (δ~H~ 4.45); **3b**: H-2′′ (δ~H~ 2.38), H-4′′ (δ~H~ 1.86), H-5′′ (δ~H~ 4.44).

The C-4′ absolute configuration of **4** was established as *S* on the basis of the Δδ values (Δδ~H--3′~: + 0.05, + 0.05; Δδ~H--5~−0.10) of the (*S*)-- and (*R*)--MTPA esters (**4a** and **4b**). **4a**: H--3′ (δ~H~ 1.64, 1.27), H-5′ (δ~H~ 1.21); **4b**: H-3′ (δ~H~ 1.59, 1.22), H-5′ (δ~H~ 1.31).

Both C-4 and C-4′ absolute configuration of **5** were established as *S* on the basis of the Δδ values (Δδ~H--3~: + 0.17; Δδ~H--5~: −0.19; Δδ~H--6~: −0.02; Δδ~H--1ΔδH--2ΔδH--3ΔδH--5~−0.07) of the (*S*)-- and (*R*)--MTPA esters (**5a** and **5b**). **5a**: H--3 (δ~H~ 4.65), H-5 (δ~H~ 7.27), H-6 (δ~H~ 7.63), H-1′ (δ~H~ 1.66, 1.53), H-2′ (δ~H~ 1.49), H-3′ (δ~H~ 1.60, 1.32), H-5′ (δ~H~ 1.25); **5b**: H-3 (δ~H~ 4.48), H-5 (δ~H~ 7.46), H-6 (δ~H~ 7.65), H-1′ (δ~H~ 1.58, 1.40), H-2′ (δ~H~ 1.46), H-3′ (δ~H~ 1.53, 1.24), H-5′ (δ~H~ 1.32).

Plant Growth Response Assays {#S2.SS6}
----------------------------

*Arabidopsis thaliana* Col-0, a model organism for plant growth and development, was used to test each isolated compound according to a previously described protocol ([@B24]; [@B14]). Plants grown in 2% (*v/v*) DMSO were used as the negative control. Seeds of Col-0 incubated in 1 μM of 6-benzylaminopurine (BAP) were selected as the positive control. Test samples were dissolved in 2% (*v/v*) DMSO at various test concentrations for the experiment.

*In vitro* AChE Activity Assays {#S2.SS7}
-------------------------------

For compounds **1**−**11**, the *in vitro* acetylcholinesterase (AChE) activity was assessed by the colorimetric method in 96-well plates according to a previously reported method ([@B32]). Donepezil was selected as the positive control with IC~50~ value of 11.9 nM ([@B4]).

*In vitro* Cancer Cell Cytotoxicity Assays {#S2.SS8}
------------------------------------------

The *in vitro* cytotoxic activities of all isolated compounds against four human cancer cell lines (CCRF-CEM, MDA-MB-231, HCT-116, and AGS) were evaluated by the MTT method as previously described ([@B14]; [@B23]). 7-Ethyl-10-hydroxycamptothecin (1.3, 10.8, 9.9, and 4.2 nM, respectively) was used as the positive control against four above-mentioned human cancer cell lines.

Antibacterial Activity Assays {#S2.SS9}
-----------------------------

Compounds **1**−**11** were evaluated for their antibacterial activities against methicillin-resistant *Staphylococcus aureus* ATCC43300 and *Escherichia coli* ATCC25922 in 96-well plates according to the method described by [@B12]. Ciprofloxacin was selected as a positive control against the above-mentioned bacteria with MIC values of 0.5 μg/mL.

*In vitro* Antimalarial Activity Assays {#S2.SS10}
---------------------------------------

The *in vitro* antimalarial activity of the compounds was evaluated against the parasite (*Plasmodium falciparum* W2), which was cultured continuously according to a previously described method ([@B18]). Chloroquine, atovaquone, and artemisinin were used as positive controls against the above parasite with EC~50~ values of 112, 2.5, and 160 nM, respectively.

Results and Discussion {#S3}
======================

Structure Elucidation {#S3.SS1}
---------------------

Compound **1** was isolated as white crystals. The molecular formula of **1** was determined to be C~14~H~18~O~5~ based on an ion peak observed in HRESIMS spectrum (*m/z* \[M - H\]^--^ 265.1082, calcd for C~14~H~17~O~5~, 265.1081), and this implied the compound has six degrees of unsaturation. The ^1^H NMR data of **1** ([Table 1](#T1){ref-type="table"}) demonstrated two aromatic signals \[(δ~H~ 7.07, d, *J* = 8.9 Hz, H-6) and (δ~H~ 6.72, d, *J* = 8.9 Hz, H-7)\] that were suggestive of two *ortho* protons. In addition, one phenolic hydroxy group at δ~H~ 10.38 (1H, s, 8-OH), two oxygenated methine groups at δ~H~ 4.59 (1H, m, H-3) and 3.60 (1H, m, H-4′), four methylene groups at δ~H~ 3.06 (1H, dd, H-4α), 2.60 (1H, dd, H-4β), 1.78 (1H, m, H-1′α), 1.68 (1H, m, H-1′β), 1.46 (2H, m, H-2′), and 1.36 (2H, m, H-3′), and one methyl group at δ~H~ 1.05 (3H, d, H-5′) were observed in the ^1^H NMR spectrum of **1**. The ^13^C NMR and DEPT spectra together for **1** indicated 14 carbon signals ([Table 1](#T1){ref-type="table"}), including a carbonyl at δ~C~ 169.5 (C-1), six aromatics at δ~C~ 153.9 (C-8), 146.6 (C-5), 124.5 (C-4a), 123.9 (C-6), 115.1 (C-7), and 108.2 (C-8a), and seven alkyl carbons that were two oxygenated methines at δ~C~ 79.4 (C-3) and 65.6 (C-4′), four hydrocarbon methylenes at δ~C~ 38.6 (C-3′), 34.3 (C-1′), 26.3 (C-4), and 20.8 (C-2′), and a methyl at δ~C~ 23.7 (C-5′). In total, the NMR data suggested the presence of a dihydroisocoumarin skeleton contained in **1**. The ^1^H−^1^H COSY correlations of H-5′/H-4′/H-3′/H-2′/H-1′ further indicated a continuous spin system in the molecule, identified as -CH~2~-CH~2~-CH~2~-CH(OH)-CH~3~ ([Figure 2](#F2){ref-type="fig"}). Furthermore, according to the key HMBC correlations presented in [Figure 2](#F2){ref-type="fig"}, including from H-2′ to C-3, from H-4 to C-1′, C-3, C-5, C-4a, and C-8a, as well as from 8-OH to C-7, C-8, and C-8a, the planar structure of **1** was established as shown. Finally, on the basis of X-ray single-crystal diffraction analysis ([Figure 3](#F3){ref-type="fig"}), the absolute configuration of **1** was established as 3*R*,4′*S*, and this new molecule was given the trivial name aspergimarin A.

![^1^H−^1^H COSY and key HMBC correlations observed for **1**−**6**.](fmicb-10-02846-g002){#F2}

![X-ray ORTEP drawing of **1.**](fmicb-10-02846-g003){#F3}

Compound **2** was obtained as a brown oil, and the molecular formula of C~18~H~22~O~8~ was assigned to this molecule by the anion HRESIMS peak at *m/z* 365.1232 \[M − H\]^--^ (calcd for C~18~H~21~O~8~, 365.1242). The ^1^H and ^13^C NMR spectroscopic data of **2** ([Table 1](#T1){ref-type="table"}) resembled those of **1**, and it was determined that the core structure of an oxygenated hydrocarbon-extended dihydroisocoumarin was shared between these molecules. The ^1^H−^1^H COSY correlation between H-2′′ and H-3′′, along with key HMBC correlations from H-3′′ (δ~H~ 2.46) to C-1′′ (δ~C~ 171.8) and C-4′′ (δ~C~ 173.5) ([Figure 2](#F2){ref-type="fig"}), indicated the existence of the linear chain -OCO-CH~2~-CH~2~-CO~2~H in the structure of **2**. Furthermore, according to the same biosynthetic pathway with **1** based on and the key HMBC correlation observed from H-4′ (δ~H~ 4.83) to C-1′′, the planar structure of **2** was established. The absolute configuration for **2** was suggested as being 3*R*,4′*S* based on the biosynthetic logic that it would match that of **1**. The CD spectra of **1** and **2** ([Figure 4](#F4){ref-type="fig"}) are able to be overlapped, with the same Cotton effects observed, which further support the configurational assignment. Accordingly, the resolved structure of compound **2** was afforded the trivial name aspergimarin B.

![Experimental ECD spectra of **1**−**6**, collected in MeOH.](fmicb-10-02846-g004){#F4}

Compound **3** was also obtained as a brown oil, and its molecular formula of C~20~H~28~O~8~ was determined by the potassium cation adduct peak in the HRESIMS spectrum at *m/z* 435.1416 \[M + K\]^+^ (calcd for C~20~H~28~KO~8~, 435.1416). The CD spectrum of **3** ([Figure 4](#F4){ref-type="fig"}) and the ^1^H and ^13^C NMR spectroscopic data ([Table 1](#T1){ref-type="table"}) were similar to those of both **1** and **2**, indicating that this molecule is another oxygenated hydrocarbon-extended dihydroisocoumarin analog with the same absolute configuration at C-3 and C-4′. It was determined from a ^1^H−^1^H COSY correlation of H-4′′/H-5′′ and the key HMBC correlations from H-2′′ (δ~H~ 2.38) to C-1′′ (δ~C~ 170.4) and C-4′′ (δ~C~ 43.7), as well as from 3′′-OH (δ~H~ 4.53) to C-2′′ (δ~C~ 46.9), C-3′′ (δ~C~ 69.8) and C-6′′ (δ~C~ 27.4) ([Figure 2](#F2){ref-type="fig"}), that there is a different secondary carbon side chain \[-OCO-CH~2~-C(CH~3~)(OH)-CH~2~-CH~2~OH\] in the molecule of **3** as compared to **2**. Furthermore, the key HMBC correlation observed from H-4′ (δ~H~ 4.83) to C-1′′ allowed for the planar structure of **3** to be completed. Since the biosynthetic logic of **3** with relation to **1** and **2**, together with the matching CD data of these molecules allowed the partial absolute configuration to be assigned as 3*R*,4′*S*, only one stereocenter remained uncertain. Using the modified Mosher's method ([Figure 5](#F5){ref-type="fig"}) ([@B12]) the absolute configuration of C-3′′ of **3** was established as being *R*. Therefore, the absolute configuration of **3** was determined to be 3*R*,4′*S*,3′′*R*.

![Modified Mosher's analysis for **3**−**5**. Values shown denote Δδ (δ~S~ −δ~R~) (ppm) for the MTPA esters of **3**−**5**.](fmicb-10-02846-g005){#F5}

Compound **4** was obtained as a yellow oil, and the molecular formula of this molecule was determined to be C~16~H~22~O~5~ was based on a peak observed in the HRESIMS spectrum at *m/z* 295.1537 \[M + H\]^+^ (calcd for C~16~H~23~O~5~, 295.1540). The data of **4** from spectroscopic analysis, including UV, IR, and NMR, were extremely similar to those reported for the known compound, penicimarin C (**9**) ([@B29]). The exceptions noted were determined to be due to the substitution of one methoxy group for a proton at C-7. The placement of the additional methoxy group at C-7 was determined from key HMBC correlations observed from H-5 (δ~H~ 7.06) to C-4 (δ~C~ 32.7), C-7 (δ~C~ 152.2), and C-8a (δ~C~ 119.0), and from 7-*O*-CH~3~ (δ~H~ 3.81) to C-7, together with the ^1^H−^1^H COSY correlation of H-5/H-6 (δ~H~ 7.28) ([Figure 2](#F2){ref-type="fig"}). Accordingly, the planar structure of **4** was unambiguously established as shown. Compared to the CD data of **1** and some previously described values for dihydroisocoumarins ([@B8]), the observed CD spectrum of **4** ([Figure 4](#F4){ref-type="fig"}) indicated the *R* configuration at C-3. The absolute configuration at the side chain was suggested as 4′*S* to match that of **1** according to biosynthetic logic, and this was confirmed by use of the modified Mosher's method ([Figure 5](#F5){ref-type="fig"}). Thus, the absolute configuration of **4** was determined to be 3*R*,4′*S*.

Compound **5** was isolated as a colorless oil, and its molecular formula was established as being C~14~H~18~O~5~ according to the associated sodiated molecular ion peak in the HRESIMS spectrum at *m/z* 289.1034 \[M + Na\]^+^ (calcd for C~14~H~18~NaO~5~, 289.1046). This formula for **5** corresponds to an additional OH with respect to **1**, and the ^1^H and ^13^C NMR data ([Table 2](#T2){ref-type="table"}) suggested shared carbon skeletons with the substitution of an additional hydroxy group. From the chemical shift differences calculated between **5** and **1**, the additional hydroxy group of **5** was suggested to be at C-4. This assignment was further supported by key HMBC correlations from H-4 (δ~H~ 4.71) to C-5 (δ~C~ 116.3) and from H-5 (δ~H~ 7.03) to C-4 (δ~C~ 67.5), together with the ^1^H−^1^H COSY correlation of H-4/H-3 (δ~H~ 4.47) ([Figure 2](#F2){ref-type="fig"}). The absolute configuration at C-3 was determined to be *R* by the comparison of CD data with **1** and **4** ([Figure 4](#F4){ref-type="fig"}). The absolute configuration of chiral centers at both C-4 and C-4′ in **5** was established as being *S* by use of the modified Mosher's method ([Figure 5](#F5){ref-type="fig"}). Therefore, the absolute configuration of **5** was determined to be 3*R*,4*S*,4′*S*.

Compound **6** was isolated as a yellow amorphous powder, and its molecular formula was determined to be C~14~H~16~O~5~ by an associated sodiated molecular ion peak in the HRESIMS spectrum at *m/z* 287.0879 \[M + Na\]^+^ (calcd for C~14~H~16~NaO~5~^+^, 287.0890). The spectroscopic data of **6**, including UV, IR, and NMR, resembled those previously reported for the known molecule penicilloxalone B (**10**) ([@B30]). From the ^1^H and ^13^C NMR data, it was obvious that the aromatic substitution patterns of **6** and **10** differed, with **6** bearing protons at C-5 and C-6 while **10** has protons at C-6 and C-7. Furthermore, the key HMBC correlations observed from H-5 (δ~H~ 6.63) to C-4 (δ~C~ 31.4), C-7 (δ~C~ 144.4), and C-8a (δ~C~ 108.4) together with the ^1^H−^1^H COSY correlation of H-5/H-6 (δ~H~ 7.00) ([Figure 2](#F2){ref-type="fig"}) corroborated that the two phenolic hydroxy groups of **6** were situated at C-7 and C-8 (δ~C~ 150.0). The absolute configuration of **6** was determined to be 3*R*, the same as for **10**, by comparison of the observed CD spectrum for this molecule with reported data for **10** ([Figure 4](#F4){ref-type="fig"}).

Five additional compounds isolated from *Aspergillus* sp. NBUF87 in the course of this study were determined, by comparison of the spectroscopic and spectrometric data of each with reported values, to be the known isocoumarin derivatives aspergillumarin B (**7**) ([@B22]), penicimarin B (**8**) ([@B29]), penicimarin C (**9**) ([@B29]), penicilloxalone B (**10**) ([@B30]), and (*R*)-3-(3-hydroxypropyl)-8-hydroxy-3,4-dihydroisocoumarin (**11**) ([@B33]). The absolute configurations for **7**-**9** were established to be 3*R*, 4′*S* because the CD spectra (see [Supplementary Figures S61](#SM1){ref-type="supplementary-material"}, [S73](#SM1){ref-type="supplementary-material"}), and optical rotation data matched literature values ([@B22]; [@B29]). The absolute configuration of **10** and **11** was also determined to be 3*R* because the optical rotation data matched literature reported values for these molecules ([@B33]; [@B30]).

Effects of Compounds **1**−**11** on Plant Growth of *Arabidopsis thaliana* Columbia-0 {#S3.SS2}
--------------------------------------------------------------------------------------

The isolated compounds **1**−**11** were subjected to bioassays for testing plant growth response using *A. thaliana* Col-0, a model plant growth organism. At 100 μM, for both **1** and **5,** root growth inhibitory activity was observed against Col-0. Interestingly, while **1** showed only significant inhibitory effect on the lateral root growth of Col-0, **5** caused notable inhibition of both lateral root and primary root growth, as shown in [Figure 6](#F6){ref-type="fig"}. Compounds **2**-**4** and **6**-**11** did not show any obvious activity in the same plant growth response assay at 100 μM.

![Responses of 100 μM addition of **1** and **5** on the root growth of *Arabidopsis thaliana* Columbia-0 at 10 days after seed germination. DMSO: negative control; BAP: positive control.](fmicb-10-02846-g006){#F6}

Results of Compounds **1**−**11** Against Four Additional Bioassays {#S3.SS3}
-------------------------------------------------------------------

All compounds isolated in this study (**1**−**11**) were also tested for their *in vitro* inhibitory activity of AChE in a biochemical assay, and phenotypic tests for cytotoxicity against four human-derived cancer cell lines, namely, CCRF-CEM (acute lymphoblastic leukemia T lymphocyte), MDA-MB-231 (breast cancer), HCT-116 (colon cancer), and AGS (gastric adenocarcinoma), and antibacterial activity toward methicillin-resistant *S. aureus* ATCC43300 and *E. coli* ATCC25922, and antimalarial activity against *P. falciparum* W2. None of these compounds exhibited inhibition of AChE (IC~50~ \> 100 μM), cytotoxic activities against any of the cell lines tested (IC~50~ \> 50 μM), antibacterial activities toward the two bacteria (MIC \> 50 μg/mL), or antimalarial activity against the parasite (EC~50~ \> 100 μg/mL).

Conclusion {#S4}
==========

In summary, six new dihydroisocoumarin derivatives, aspergimarins A−F (**1**−**6**) were obtained along with five known analogs (**7**−**11**) from the fermentation of a fungus *Aspergillus* sp. NBUF87, isolated from the sponge *Hymeniacidon* sp. collected from the Paracel Islands in the South China Sea. Structurally, compounds **2** and **3** are esters of the C-4′ hydroxy group in the C-3 side chain of **1**, representing relatively rare isocoumarin derivatives according to previous literature reports ([@B31]). In a plant growth response assay using *A. thaliana* Col-0 as a model organism, only **1** and **5** showed inhibitory activity against root growth, while the others were inactive at up to 100 μM. This finding indicates that the substitution pattern of hydroxy groups in these dihydroisocoumarins may play an important role in root growth inhibitory activity, and further studies remain necessary to interrogate this phenomenon. Since none of the isolated compounds, including **1** and **5**, were found to be broadly AChE inhibitors, anticancer agents, antibacterial agents, or antimalarial agents, it is proposed that these root growth inhibitors act through more elaborate signaling pathways. Moreover, **1** and **5** were here as the root growth inhibitors of Col-0, suggesting that they have an important impact in agricultural production.
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